A Phase 1 Open-Label, Multicenter Study to Evaluate
Biomarkers for ZN-c5 in Subjects with Estrogen
Receptor-Positive, Human Epidermal Growth Factor
Receptor 2-Negative Breast Cancer
** For Eligibility information, please click on the "Look up trial at NIH" link above **
Other eligibility criteria may apply.
Other exclusion criteria may apply.